FLIRT
Etude de deux stratégies d’administration du rituximab (IV et SC) en première ligne chez des patients atteints d'un Lymphome Folliculaire de faible masse tumorale (phase III)Poster FLIRT | ASCO 2022 |
---|---|
G. Cartron, E Bachy, H Tilly, N Daguindau, GM Pica, F Bijou, C Mounier, A Clavert, GL Damaj, B Slama, O Casasnovas, R Houot, K Bouabdallah, D Sibon, O Fitoussi, N Morineau, F Morschhauser, L Xerri, K Tarte, D Pranger | Sub- Cutaneous Rituximab Induction Followed by Short Rituximab Maintenance Improves Progression-Free Survival in Patients with Low-Tumor Burden Follicular Lymphoma. Final Results of FLIRT Phase III Trial, a LYSA Study. |
Publications 2021
Lysa
2021_LYSA_Extracellular vesicles shed by follicular lymphoma B cells promote polarization of the bone marrow stromal cell niche
Blood . 2021 Jul 8;138(1):57-70.
En savoir plus
Lysa
2021_LYSA_Follicular lymphoma triggers phenotypic and functional remodeling of the human lymphoid stromal cell landscape
Immunity . 2021 Aug 10;54(8):1901.
En savoir plus